Published in
Elsevier, Cancer Treatment Reviews, (57), p. 8-15, 2017
DOI: 10.1016/j.ctrv.2017.04.005
Links
Tools
Tumor-infiltrating lymphocytes in patients with HER2-positive breast cancer treated with neoadjuvant chemotherapy plus trastuzumab, lapatinib or their combination: A meta-analysis of randomized controlled trials
Journal article published in 2017 by
C. Solinas,
M. Ceppi 
,
M. Lambertini,
M. Scartozzi,
L. Buisseret,
S. Garaud,
D. Fumagalli,
E. de Azambuja,
R. Salgado,
C. Sotiriou,
K. Willard-Gallo,
M. Ignatiadis
,
M. Lambertini,
M. Scartozzi,
L. Buisseret,
S. Garaud,
D. Fumagalli,
E. de Azambuja,
R. Salgado,
C. Sotiriou,
K. Willard-Gallo,
M. Ignatiadis
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 